Stay Connected.
Get the inside scoop on company and product news. Subscribe to PBInsider, our quarterly e-newsletter, today!
Have you registered?
April 26, 2024
Join Precision BioLogic’s Chief Scientific Officer F. Jon Geske, PhD and Marketing Director Ian Burns as they explore chromogenic factor VIII and factor IX testing along with emerging hemophilia treatments.
Wednesday May 8, 2024, 1–2 p.m. Eastern
Topics include:
- Current and emerging non-factor therapies
- Extended half-life treatments
- Gene therapy for hemophilia A and B
- Chromogenic burning questions
Jon and Ian will also provide some updates on what we’re up to at Precision BioLogic.